TD Asset Management
GPCR icon

TD Asset Management’s Structure Therapeutics GPCR Stock Holding History

TD Asset Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Sell
68,962
-135,800
-66% -$6.01M ﹤0.01% 871
2026
Q1 		$9.87M Buy
204,762
+30,088
+17% +$2.06M 0.01% 648
2025
Q4 		$12.1M Buy
174,674
+138,588
+384% +$5.66M 0.01% 607
2025
Q3 		$1.01M Sell
36,086
-7,600
-17% -$151K ﹤0.01% 1088
2025
Q2 		$906K Hold
43,686
– – ﹤0.01% 1074
2025
Q1 		$756K Sell
43,686
-45,196
-51% -$1.11M ﹤0.01% 1103
2024
Q4 		$2.41M Sell
88,882
-101,874
-53% -$3.61M ﹤0.01% 954
2024
Q3 		$7.96M Sell
190,756
-20,834
-10% -$806K 0.01% 689
2024
Q2 		$8.31M Buy
211,590
+68,490
+48% +$2.81M 0.01% 655
2024
Q1 		$6.13M Sell
143,100
-14,158
-9% -$597K 0.01% 727
2023
Q4 		$6.41M Buy
157,258
+5,082
+3% +$291K 0.01% 699
2023
Q3 		$7.67M Buy
152,176
+79,467
+109% +$2.56M 0.01% 634
2023
Q2 		$3.02M Buy
72,709
+36,763
+102% +$1.03M ﹤0.01% 852
2023
Q1 		$855K Buy
+35,946
New +$845K ﹤0.01% 1164

Other funds holding GPCR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
CLGM
Capitolis Liquid Global Markets New York $23B AUM 48.97% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $587M AUM
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

TD Asset Management's GPCR Position: Q2 2026 in Review

TD Asset Management reduced its Structure Therapeutics (GPCR) stake by 66% in Q2 2026, selling an estimated $6.01M and leaving 68,962 shares worth $3.7M. The position accounts for ﹤0.01% of the portfolio, ranked #871.

TD Asset Management first reported a position in GPCR in Q1 2023 and has held it in 14 quarters since. The position peaked at $12.1M in Q4 2025. 110 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • TD Asset Management held 68,962 shares of Structure Therapeutics worth $3.7M as of Q2 2026.
  • TD Asset Management sold 135,800 Structure Therapeutics shares in Q2 2026, an estimated $6.01M.
  • Structure Therapeutics made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #871 holding.
  • TD Asset Management first reported a position in Structure Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • TD Asset Management's Structure Therapeutics position peaked at $12.1M in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.